Skip to main content
Equibles

UBS Group AG

Position in DXCM — Dexcom Inc

CIK 1610520 ZURICH, V8
Back to DXCM Full portfolio

Position in DXCM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$408,530,211
+$135,352,789 QoQ
Shares Held
6,065,779
+39.4% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#13
of 976 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in DXCM Over Time

Shares Held

Position Value (USD)

Derivatives in DXCM

reported options exposure · as of Jun 30, 2026
CallValue
$15,133,545
CallShares
224,700
PutValue
$31,896,960
PutShares
473,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,686,450,066 across 138 Medical Devices names. DXCM ranks #5 (8.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 16,352,420 $697,921,281
2 ABT
Abbott Laboratories
 7,356,093 $667,491,874
3 SYK
Stryker Corp
 1,909,680 $601,243,647
4 MDT
Medtronic plc
 5,551,443 $434,289,383
5 DXCM
Dexcom Inc
This page 		6,065,779 $408,530,211
6 ZBH
Zimmer Biomet Holdings, Inc.
 2,758,615 $237,489,163
7 PEN
Penumbra Inc
 703,822 $222,231,795
8 EW
Edwards Lifesciences Corp
 2,350,656 $212,640,338

All Filings in DXCM

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,896,960 473,600
2026-06-30 $408,530,211 6,065,779
2026-06-30 $15,133,545 224,700
2026-03-31 $31,073,440 494,800
2026-03-31 $30,966,428 493,096
2026-03-31 $273,177,422 4,349,959
2025-12-31 $50,991,805 768,296
2025-12-31 $127,681,274 1,923,780
2025-12-31 $40,001,199 602,700
2025-09-30 $45,508,227 676,300
2025-09-30 $198,917,447 2,956,122
2025-09-30 $44,377,755 659,500
2025-06-30 $25,671,989 294,100
2025-06-30 $168,704,595 1,932,691
2025-06-30 $31,616,438 362,200
2025-03-31 $29,788,098 436,200
2025-03-31 $25,991,174 380,600
2025-03-31 $136,205,084 1,994,510
2024-12-31 $39,896,010 513,000
2024-12-31 $27,499,472 353,600
2024-12-31 $151,471,536 1,947,686
2024-09-30 $36,959,152 551,300
2024-09-30 $29,095,360 434,000
2024-09-30 $94,681,527 1,412,314
2024-06-30 $135,748,850 1,197,291
2024-06-30 $32,335,976 285,200
2024-06-30 $27,807,578 245,260
2024-03-31 $154,326,356 1,112,663
2024-03-31 $32,963,442 237,660
2024-03-31 $32,525,150 234,500
2023-12-31 $20,909,165 168,500
2023-12-31 $22,703,506 182,960
2023-12-31 $127,592,810 1,028,228
2023-09-30 $100,142,434 1,073,338
2023-09-30 $18,380,100 197,000
2023-09-30 $33,979,860 364,200
2023-06-30 $24,596,814 191,400
2023-06-30 $16,333,621 127,100
2023-06-30 $121,674,166 946,807
2023-03-31 $7,238,014 62,300
2023-03-31 $8,237,162 70,900
2023-03-31 $71,035,238 611,424
2022-12-31 $11,032,067 97,422
2022-12-31 $138,379 1,222
2022-12-31 $75,429,163 666,100
2022-09-30 $4,027,000 50,000
2022-09-30 $28,101,208 348,910
2022-06-30 $32,928,318 441,813
2022-03-31 $65,598,373 128,222
2021-12-31 $99,517,236 185,338